SCHEMBL18878285

SCHEMBL18878285

CC1(C)c2ccccc2-c2cc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccc(-c6ccccc6)cc5)n4)cc3)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
PDK2 Q15119 5/20 0.41
LMNA P02545 3/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
ATM Q13315 2/20 0.38
APAF1 O14727 1/20 0.38
NPC1 O15118 1/20 0.38
THRB P10828 1/20 0.38
XBP1 P17861 1/20 0.38
PTBP1 P26599 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
GALK1 P51570 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23697401 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17887165 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL31664378 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17151714 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17151700 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24128800 0.97 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24128727 0.97 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17887221 0.97 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22986992 0.97 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22037587 0.97 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021150048-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2021-07-29 WO disclosed
US-20210074925-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-11 US disclosed
EP-3174123-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG Display Co., Ltd. (KR) 2017-05-31 EP disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 MEN1 3213/4885KMT2A 626/4885MAPT 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.